Republic of Moldova vs Qatar: Opioid use disorder deaths by sex
Republic of Moldova
0.43 deaths
in 2021
Qatar
0.37 deaths
in 2021
Republic of Moldova rank
129th
Qatar rank
131st
Opioid use disorder deaths by sex over time
- Republic of Moldova
- Qatar
How they compare
Republic of Moldova currently reports 0.43 deaths against 0.37 deaths in Qatar, a difference of 0.06 deaths.
That makes Republic of Moldova's figure about 1.2 times Qatar's.
The two have swapped places 8 times across 22 shared years of data; in 2000 it was Republic of Moldova ahead.
Republic of Moldova ranks 129th and Qatar ranks 131st of 194 countries.
Across the 3 decades both report, Republic of Moldova averaged higher in 2 and Qatar in 1.
Head to head by decade
| Decade | Republic of Moldova | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.39 deaths | 0.203 deaths | 2.19 deaths | Republic of Moldova |
| 2010s | 0.907 deaths | 0.407 deaths | 0.5 deaths | Republic of Moldova |
| 2020s | 0.335 deaths | 0.395 deaths | 0.06 deaths | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher opioid use disorder deaths by sex, Republic of Moldova or Qatar?
- Republic of Moldova, at 0.43 deaths against 0.37 deaths in Qatar as of 2021.
- What is the difference in opioid use disorder deaths by sex between Republic of Moldova and Qatar?
- 0.06 deaths, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Qatar?
- 22 years are reported by both, from 2000 to 2021.
- How do Republic of Moldova and Qatar rank globally for opioid use disorder deaths by sex?
- Republic of Moldova ranks 129th and Qatar ranks 131st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Opioid use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from opioid use disorders in females.